Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$VCYT—Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it…

Continue Reading
Global Healthcare Innovator Qure.ai Expands Executive Team With Eminent Lung Health Appointment to Accelerate Clinical Strategy | Region

Global Healthcare Innovator Qure.ai Expands Executive Team With Eminent Lung Health Appointment to Accelerate Clinical Strategy | Region

NEW YORK–(BUSINESS WIRE)–Aug 20, 2025– Qure.ai has appointed Dr. Javier J. Zulueta, previously Professor of Medicine…

Continue Reading
Global Healthcare Innovator Qure.ai Expands Executive Team With Eminent Lung Health Appointment to Accelerate Clinical Strategy

Global Healthcare Innovator Qure.ai Expands Executive Team With Eminent Lung Health Appointment to Accelerate Clinical Strategy

Dr. Javier J Zulueta, Chief Medical Officer, Pulmonology, Qure.ai Dr. Javier J. Zulueta enters boardroom as…

Continue Reading
Carta Healthcare Secures .25 Million in Series B1 Funding to Accelerate AI-Powered Clinical Data Abstraction and Analytics

Carta Healthcare Secures $18.25 Million in Series B1 Funding to Accelerate AI-Powered Clinical Data Abstraction and Analytics

Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General…

Continue Reading